Prepare for launch with a customized strategy.
We combine our experience across therapeutic areas, rare diseases, biologics, vaccines, cell and gene therapies, and autologous & allogeneic cellular therapies with innovative perspectives to deliver bespoke strategies for the entirety of your launch.
Centered on deep vertical expertise and paired with a pioneering ethos, we combine our scientific and industry experience with proven frameworks to support launch planning, engage with stakeholders, and support medical affairs structure and metric requirements.
We can help you with:
Get the latest insights and perspectives from our experts.
The evolution of Medical Affairs as a pivotal strategic leader at this year’s sold-out Medical Affairs Professional Society (MAPS).
A global, top-10 pharma client sought Putnam’s guidance on developing a lean launch strategy for a novel cell therapy in oncology.
Putnam helped the client to support development of local medical launch readiness plans for a new vaccine.
Read how our client aims to locate organizations advancing AI algorithms for rare disease detection.
Looking to get in touch with an expert or team member?
Tell us how we can help.
